Patents by Inventor Richard Hiipakka

Richard Hiipakka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liver X receptor agonists
    Patent number: 8829213
    Abstract: Compounds of formula (I): in which R1, R2, R3, R3?, R4, R5, R6, R6?, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, A, D, X, Y, and Z are defined in the specification. Also disclosed is a method of using one of the compounds to lower the blood cholesterol level and treat cancer, atherosclerosis, diabetes, Alzheimer's disease, and corneal arcus.
    Type: Grant
    Filed: July 29, 2010
    Date of Patent: September 9, 2014
    Assignee: The University of Chicago
    Inventors: Dacheng Peng, John Kokontis, Richard Hiipakka, Shutsung Liao
  • LIVER X RECEPTOR AGONISTS
    Publication number: 20110059932
    Abstract: Compounds of formula (I): in which R1, R2, R3, R3?, R4, R5, R6, R6?, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, A, D, X, Y, and Z are defined in the specification. Also disclosed is a method of using one of the compounds to lower the blood cholesterol level and treat cancer, atherosclerosis, diabetes, Alzheimer's disease, and corneal arcus.
    Type: Application
    Filed: July 29, 2010
    Publication date: March 10, 2011
    Applicant: The University of Chicago
    Inventors: Dacheng Peng, John Kokontis, Richard Hiipakka, Shutsung Liao
  • Polyhydroxylated benzene-containing compounds
    Publication number: 20050113426
    Abstract: A method for reducing food intake in a subject and a method for reducing the levels of an endocrine in a subject. The methods include administering to the subject in need thereof an effective amount of a compound of the formula: Also disclosed is a liposomal preparation which includes a liposome and a compound entrapped therein. The entrapped compound is of the formula shown above.
    Type: Application
    Filed: August 20, 2003
    Publication date: May 26, 2005
    Inventors: Shutsung Liao, Richard Hiipakka, Yung-Hsi Kao
  • Method and compositions for regulation of 5-alpha reductase activity
    Patent number: 6696484
    Abstract: Pharmaceutical compositions and methods for treating androgen related disorders. The pharmaceutical compositions may include a 5&agr;-reductase inhibitor, such as natural and synthetic flavanoids, catechols, curcumin-related substances, quinones, catechins, particularly epigallocatechin derivatives, fatty acids, and the salts, esters, analogues, pro-drugs, isomers, racemic mixtures, or derivatives of any of the foregoing. The use of testosterone (or DHT) combinations with the aforementioned 5&agr;-reductase inhibitor compounds is also contemplated.
    Type: Grant
    Filed: April 24, 2002
    Date of Patent: February 24, 2004
    Assignee: University of Chicago Office of Technology and Intellectual Property
    Inventors: Shutsung Liao, Richard Hiipakka
  • Polyhydroxylated benzene-containing compounds
    Patent number: 6610749
    Abstract: A method for reducing food intake in a subject and a method for reducing the levels of an endocrine in a subject comprising administering to the subject in need thereof an effective amount of a compound of the formula: wherein A is alkenyl, and each of Ra, Rb, Rc and Rd is herein defined.
    Type: Grant
    Filed: February 15, 2001
    Date of Patent: August 26, 2003
    Assignee: ARCH Development Corporation
    Inventors: Shutsung Liao, Richard A. Hiipakka, Yung-Hsi Kao
  • Methods and compositions for regulation of 5-alpha reductase activity
    Publication number: 20030144346
    Abstract: Compounds that inhibit 5&agr;-reductase are provided. The compounds are used to treat prostate cancer, breast cancer, obesity, skin disorders and baldness.
    Type: Application
    Filed: November 14, 2002
    Publication date: July 31, 2003
    Inventors: Shutsung Liao, Richard A. Hiipakka
  • Polyhydroxylated benzene-containing compounds
    Publication number: 20030139477
    Abstract: A method for reducing food intake in a subject and a method for reducing the levels of an endocrine in a subject.
    Type: Application
    Filed: February 15, 2001
    Publication date: July 24, 2003
    Inventors: Shutsung Liao, Richard A. Hiipakka, Yung-Hsi Kao
  • Methods and compositions for regulation of 5-&agr;-reductase activity
    Patent number: 6576660
    Abstract: Compounds that inhibit 5-alpha-reductase are provided. The compounds are used to treat prostate cancer, breast cancer, obesity, skin disorders and baldness.
    Type: Grant
    Filed: April 28, 2000
    Date of Patent: June 10, 2003
    Assignee: Arch Development Corporation
    Inventors: Shutsung Liao, Richard A. Hiipakka
  • Method and compositions for regulation of 5-alpha reductase activity
    Publication number: 20030105030
    Abstract: Pharmaceutical compositions and methods for treating androgen related disorders. The pharmaceutical compositions may include a 5&agr;-reductase inhibitor, such as natural and synthetic flavanoids, catechols, curcumin-related substances, quinones, catechins, particularly epigallocatechin derivatives, fatty acids, and the salts, esters, analogues, pro-drugs, isomers, racemic mixtures, or derivatives of any of the foregoing. The use of testosterone (or DHT) combinations with the aforementioned 5&agr;-reductase inhibitor compounds is also contemplated.
    Type: Application
    Filed: April 24, 2002
    Publication date: June 5, 2003
    Inventors: Shutsung Liao, Richard Hiipakka